If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...
DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab, Endpoints News reports. The St. Louis facility was one of about 30 FDA ...
Chemicals such as titanium dioxide and potassium bromate, whose safety has been debated, are allowed in foods in the United ...
and Mesa, Ariz. related to concerns about manufacturing processes and quality management systems. The FDA cited issues with DexCom's response to prior inspection findings, known as Form 483 ...